Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Overall, the European Stroke Organisation Conference (ESOC) 2026 showcased a field that continues to evolve rapidly through increasingly individualized approaches. Rather than expanding indications indiscriminately, the conference emphasized precision medicine, using advanced imaging, personalized hemodynamic targets and adjunctive therapies to identify the patients most likely to benefit while avoiding unnecessary interventions. This balance between innovation and careful patient selection may represent the defining message of ESOC 2026.”
This editorial summarizes key trials from the European Stroke Organisation Conference (ESOC) 2026, highlighting a shift toward precision medicine in acute stroke care and secondary prevention using individualized hemodynamic targets, adjunctive therapies, and advanced imaging.
to support language editing, improve readability and refine the manuscript's structure.
No takes yet. Share an insight, caveat, or question.
Rizzo et al. (2026) conducted an editorial in Acute stroke. Acute stroke reperfusion, adjunctive neuroprotection, and secondary prevention strategies vs. Standard medical therapy or control was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: